Summertime calls for a transform in the regime for your lovable pet dogs as the increase in mercury can make them susceptible to several summer months diseases. Getting them out when it is really very hot can lead to troubles like heatstroke, dehydration, sunburn aside from a variety of other wellness troubles. Early mornings and late evenings are the very best as far as everyday walks are anxious. Aside from that plenty of water should be made available to them and hydrating meals this sort of as watermelon (no seeds), cucumbers, celery are superior food selections for them. You can also shift your pet to a cooler location in your residence to prevent them from heat-linked ailments. (Also browse: Women’s Working day: 5 causes gals are opting for pets more than intimate partners)
“Summertime is a superb time of calendar year for puppies and their entrepreneurs, but it can also bring some popular ailments. As temperatures increase, canine are a lot more vulnerable to certain well being complications,” states Dr. Aishwarya R, Veterinary officer, Wiggles in a conversation with HT Electronic.
Dr Aishwarya also shares the list of common summer illnesses in canine and how to prevent them:
1. Dehydration: With larger temperatures and greater out of doors activity, dogs are at chance of dehydration. Symptoms include things like lethargy, dry gums, and sunken eyes. To prevent dehydration, ensure your pet has access to a lot of clean h2o and prevent extreme work out in the course of the most popular sections of the day.
2. Heatstroke: Heatstroke is a major condition that can be existence-threatening for dogs. Signals of heatstroke include excessive panting, drooling, vomiting, and decline of consciousness. To protect against heatstroke, prevent leaving your doggy in a scorching car, provide a good deal of shade and h2o, and restrict work out in the course of peak temperatures.
3. Sunburn: Canine with light-weight-colored fur or skinny coats are at chance of sunburn, primarily on their noses and ears. Use pet-harmless sunscreen or avoid extended publicity to immediate sunlight through peak hours.
4. Fleas and ticks: Fleas and ticks prosper in warm, humid environments and can result in major wellbeing issues for puppies. Use flea and tick avoidance goods, test your canine frequently for these pests and prevent walking your pet in parts with significant grass or brush.
5. Allergies: Summer can convey a selection of allergens that can induce allergic reactions in puppies, which include pollen, grass, and insect bites. Enjoy for symptoms of itching, redness, and swelling, and consult with with your veterinarian about allergy treatments.
6. Ear bacterial infections: Swimming in lakes or swimming pools can increase the hazard of ear infections in dogs. Dry your dog’s ears just after swimming and prevent submerging their head totally in water.
“In conclusion, summer season can be a enjoyment time for dogs, but it really is vital to get precautions to stop frequent summer months ailments. By keeping vigilant and taking actions to hold your pet interesting, hydrated, and secured, you can assist guarantee a nutritious and content summertime for your furry friend,” claims Dr Aishwarya.
hRGCs maintain mitochondrial mass by simultaneous degradation and biogenesis of mitochondria under damage. a, b Representative confocal immunofluorescence images of H7-hRGCs against mitochondrial Tom20, tdTomato, and DAPI after indicated 10 μM CCCP treatment timepoints. Scale bars are 5 μm. c, d Quantification of Tom20 intensity per cell area from sum projections of confocal z-stacks, normalized to corresponding DMSO. n = 14–42 cells per condition. e, f Mitochondrial DNA copy number analyzed by qPCR for mitochondrial ND1 gene relative to nuclear RNase P. Results shown as ΔΔCt fold changes relative to DMSO control for different times points of 10 μM CCCP treatment. n = 3, 3 technical repeats averaged for each biological repeat. g Schematic of MTDR flow experiments for tracking degrading versus newly synthesized mitochondria. h Mitochondrial mass in single cells at different CCCP (10 μM) treatment time points for degradation or m different timepoints post CCCP (10 μM) wash for biogenesis were measured by flow cytometer, and the average fluorescence intensity normalized to DMSO was plotted. n = 3. i, k Representative western blot images of LC3B and actin from i hRGCWT and k hRGCE50K treated with CCCP (10 μM) for the indicated timepoints. j, l Quantification of the ratio of LC3B-II to corresponding LC3B-I for each condition. n = 3. ٭p-value < 0.05, ٭٭p-value < 0.01, ٭٭٭p-value < 0.001, ٭٭٭٭p-value < 0.0001. Unpaired student’s t-test between independent datasets. Error bars are SEM. Credit: Communications Biology (2023). DOI: 10.1038/s42003-023-04576-w
Indiana University School of Medicine researchers have identified a new therapeutic target that could lead to more effective treatment of glaucoma.
Glaucoma is a neurodegenerative disease that causes vision loss and blindness due to a damaged optic nerve. More than 200,000 people are affected by glaucoma in the United States each year. Unfortunately, there is currently no treatment. In a newly published paper in Communications Biology, researchers found neurons use mitochondria for a steady source of energy, and restoring mitochondrial homeostasis in the diseased neurons can protect the optic nerve cells from being damaged.
“Age-related neurodegenerative disease, which includes glaucoma, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS), is the biggest global health problem,” said Arupratan Das, Ph.D., assistant professor of ophthalmology and principal investigator of the study.
“The fundamental mechanisms that we discovered can be used to protect neurons in glaucoma and be tested for the other diseases. We have identified a critical step of complex mitochondrial homeostasis process, which rejuvenates the dying neuron, similar to giving a lifeline to a dying person.”
The research team, led by Michelle Surma and Kavitha Anbarasu from the Department of Ophthalmology, used induced pluripotent stem cells (iPSCs) from patients with and without glaucoma as well as clustered regularly interspaced short palindromic repeats (CRISPR) engineered human embryonic stem cells with glaucoma mutation.
Using stem cell differentiated retinal ganglion cells (hRGCs) of the optic nerve, electron microscopy and metabolic analysis, researchers identified glaucomatous retinal ganglion cells suffer mitochondrial deficiency with more metabolic burden on each mitochondrion. This leads to mitochondrial damage and degeneration. Mitochondria are the tube like structures in cells which produce adenosine triphosphate, cell’s energy source.
However, the process could be reversed by enhancing mitochondrial biogenesis by a pharmacological agent. The team showed retinal ganglion cells are highly efficient in degrading bad mitochondria, but at the same time producing more to maintain homeostasis.
“Finding that retinal ganglion cells with glaucoma produce more adenosine triphosphate even with less mitochondria was astonishing,” Das said. “However, when triggered to produce more mitochondria, the adenosine triphosphate production load was distributed among more mitochondrion which restored the organelle physiology. It is similar to a situation where a heavy stone is carried by fewer people versus a greater number of people—each person will have less pain and injury, just like each mitochondrion will have less difficulty and damage.”
In the future, Das would like to test if these mechanisms protect the optic nerve in animal models under injury before testing in humans to hopefully lead to new clinical interventions.
More information:
Michelle Surma et al, Enhanced mitochondrial biogenesis promotes neuroprotection in human pluripotent stem cell derived retinal ganglion cells, Communications Biology (2023). DOI: 10.1038/s42003-023-04576-w
Provided by
Indiana University School of Medicine
Citation:
Researchers discover therapeutic target to aid in glaucoma treatment (2023, March 10)
retrieved 11 March 2023
from https://medicalxpress.com/news/2023-03-therapeutic-aid-glaucoma-treatment.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
CHARLESTON, W.Va. — West Virginia’s Republican supermajority Senate followed a growing national trend of GOP opposition to health care for transgender youth by passing a bill that would ban certain treatments and therapies, while approving a significant change to add exceptions for mental health.
The Senate version of the bill passed by a count of 30-2 on Friday was noteworthy in the addition of allowances for some transgender youth to continue receiving medical interventions, including hormone therapy, when they are considered at risk of self harm or suicide.
The bill faces steep opposition in the state House of Delegates, which will take up the amended Senate version. The GOP-dominated House last month passed a proposal including a ban on puberty-blocking medication and hormone therapy, with no exemptions for mental health.
Republican Gov. Jim Justice has not taken a public stance on the measure.
Lawmakers in West Virginia and other states advancing bans on transgender health care for youth and young adults often characterize gender-affirming treatments as medically unproven, potentially dangerous in the long term and a symptom of “woke” culture.
Every major medical organization, including the American Medical Association, the American Academy of Pediatrics and the American Psychiatric Association, supports gender-affirming care for youths.
The West Virginia Senate bill passed Friday would outlaw those under 18 from being prescribed hormone therapy and fully reversible medication suspending the physical changes of puberty, buying patients and parents time to make future decisions about hormones.
“These kids struggle, they have incredible difficulties,” said Majority Leader Tom Takubo, a pulmonologist, who urged support for mental health protections.
Takubo’s approved change would allow young people to access puberty blockers and hormone therapy if they are experiencing severe gender dysphoria, under certain circumstances.
Gender dysphoria is defined by medical professionals as severe psychological distress experienced by those whose gender identity differs from their sex assigned at birth.
The rate of suicide ideation for transgender youth in Virginia is three times higher than the rate for all youth in the state, according to research and data complied by WVU Medicine physicians using the West Virginia Youth Risk Behavior Survey.
During a speech on the Senate floor, Takubo referenced 17 peer-reviewed studies showing a significant decrease in the rates of suicide ideation and suicide attempts among youth with severe gender dysphoria who have access to medication therapy.
He found a supporter in Senate Health and Human Resources Committee Chair Sen. Mike Maroney, another trained physician, who said lawmakers would set “a dangerous precedent” by disregarding medical research in favor of political gain.
“Who are we, to win an election, to tell people how to practice medicine? To change treatments? It’s unbelievable,” the Republican said, adding that lawmakers wouldn’t apply the same standard for drugs for cancer or mental illness.
The legislation also includes a ban on gender-affirming surgery for minors, something medical professionals emphasize does not happen in West Virginia.
During Friday’s debate, Republican Sen. Eric Tarr repeated those concerns, saying the medical interventions doctors are practicing are too extreme and driven by “woke” culture.
“They’re trying to take pronouns out of our textbooks for kids,” Tarr said.
With Takubo’s change, a person under 18 would have to be diagnosed with severe gender dysphoria by at least two medical or mental health providers to access medication therapy. One would have to be a mental health provider or adolescent medicine specialist.
The dosage must be the lowest possible necessary to “treat the psychiatric condition and not for purposes of gender alteration,” according to the bill.
The providers must be specifically trained to diagnose and treat severe gender dysphoria in adolescents and would have to provide written testimony that medical interventions are necessary to prevent or limit self-harm or the possibility of self-harm.
The minor’s parents and guardians also would be required to give written consent to the treatments.
Hormonal therapy could not be provided to minors before the age of puberty, something West Virginia physicians say doesn’t happen anyway.
The House version of the bill passed last month 84-10, with all ‘no’ votes coming from the body’s shrinking delegation of Democrats. They accused GOP lawmakers of putting children’s lives at risk to score political points with the national conservative movement.
That version provides exceptions for individuals born with a “medically verifiable disorder” including people with “external biological sex characteristics that are irresolvably ambiguous” and for people taking treatments for infection, injury, disease, or disorder that has been “caused by or exacerbated by the performance of gender transition procedures.”
People also can access the treatment if they are in “imminent danger of death, or impairment of a major bodily function unless surgery is performed.”
Speaking against Takubo’s amendment Friday, Republican Sen. Mark Maynard said he didn’t see why any changes were necessary. He worried additions could make the state vulnerable to a lawsuit.
“This amendment would disintegrate the clarity of the bill in its very simple terms,” Maynard said. “These guardrails are already in this bill as it came to us from the House.”
The vote came a day after a crowd of protesters descended on the state Capitol, where cries of “trans kids matter” could be heard from the Senate chamber as lawmakers debated bills.
Democratic Del. Danielle Walker, the only openly LGBTQ member, led chants of the state motto: “Mountaineers are always free.”
“They are trying to come for trans kids in West Virginia, and they’re going to come for every single one of us next,” said Sam Green of Huntington, wearing a transgender pride flag draped around their shoulders while addressing the crowd.
Cecelia Moran, an 18-year-old high school student from Marion County, said she feared banning any kind of medically proven health care could result in more young people leaving West Virginia, one of only three states to lose population in the 2020 U.S. Census.
“I think a lot of young people already struggle to stay here and feel welcome here and are already planning on getting out of the state as soon as possible,” she said.
Her mother, Rebecca Moran, said the bill is “just completely unnecessary” and decisions about healthcare should be made by families and health care providers.
“This is not what’s harming our kids,” said Rebecca Moran, a city councilor in Fairmont. “There’s so many other things: homelessness, poverty.”
In the fast-paced and competitive world of health and fitness, building a successful brand takes more than just a passion for wellness.
Mari Llewellyn, the founder of Bloom Nutrition, knows this all too well. Her journey to the top wasn’t easy but she persevered and created a thriving business that inspires people to lead healthier, happier lives.
If you look at her on Instagram, it’s hard to imagine that she wasn’t always the epitome of health.
But at one point in her life, Llewellyn weighed 250 pounds. She was also diagnosed with Borderline Personality Disorder, a mental disorder characterized by unstable moods, behavior, and relationships.
She recalls a lot of self-loathing and how she could barely stand to look at herself in the mirror. Her low self-esteem led her down a path of unhealthy habits that left her feeling utterly depleted.
Llewellyn reached a turning point when she decided to take control of her life and embarked on a journey of self-discovery. She became passionate about fitness and nutrition and started sharing her knowledge with others.
She posted a body transformation video, on Instagram, that led to hundreds of DMs asking about her workout plan.
So, she went down to Kinkos and created a PDF guide to her workouts and sold them on Instagram for $5.
Llewellyn said, “We sold a ton of PDF workout guides. We sold thousands of guides.”
She knew that she had found her calling and wanted to build a bigger business around it.
So, she and her husband Greg took all of the money they made from the PDF guides and invested it into exercise bands.
Once they decided on a prototype, they had 1,000 bands shipped to her father’s house. They hunkered down and actually wrote the shipping labels, by hand, and all 1,000 themselves.
They relied exclusively on Mari’s Instagram to promote the product. It was an immediate hit and turned out to be an incredible business.
But a trip to a local GNC showed her that maybe they could create an even larger business.
She went there to buy some pre-workout powder and noticed that all the supplements, and marketing, in the store was geared towards men.
Think lots of reds and yellows and pictures of things exploding. That didn’t resonate with her at all.
She wanted to build a product that spoke to people like her and her community. That’s when Bloom Nutrition was born.
Llewellyn focused on a few key products that she knew would be effective, rather than creating a wide range of options.
She said, “Having a wider variety of products can be confusing to the customer. Specializing in one thing allows companies to make it even better and keep improving. I think that simplicity scales. And when you focus on a product that you want to do really well; that’s the key to success.”
And Bloom Nutrition’s success has exceeded Llewellyn’s wildest expectations. Last week, it was announced that Bloom Nutrition products are now available in Wal-Mart stores nationwide.
Her journey to success was anything but easy but her commitment to health and wellness kept her going. Her story serves as a testament to the power of passion and perseverance.
Llewellyn said, “The most successful businesses and the most successful people are people who are truly, truly passionate about what they’re doing.”
Jane Prior, Chief Marketing Officer at The Vita Coco Company, said, “Mari’s authentic approach to building meaningful relationships has created a supportive, uplifting community that inspires people to take charge of their well-being in an accessible way.”
Llewellyn is proof that with passion, perseverance and a little bit of hustle, anything is possible.
Damian Williams, the United States Attorney for the Southern District of New York, Michael J. Driscoll, the Assistant Director in Charge of the New York Field Office of the Federal Bureau of Investigation (“FBI”), and Fernando P. McMillan, the Special Agent in Charge of the New York Field Office of the U.S. Food and Drug Administration – Office of Criminal Investigations (“FDA-OIC”), announced today the filing of a two-count Indictment (the “Indictment”) charging Laura PERRYMAN, the former Chief Executive Officer (“CEO”) of STIMWAVE LLC, a Florida-based medical device company, in connection with a scheme to create and sell a non-functioning dummy medical device for implantation into patients suffering from chronic pain, resulting in millions of dollars in losses to federal healthcare programs. PERRYMAN was arrested this morning in Delray Beach, Florida, and will be presented later today in the United States District Court for the Southern District of Florida.
In addition, Mr. Williams announced the unsealing of a non-prosecution agreement (the “Agreement”) with STIMWAVE LLC (“STIMWAVE”), which filed for bankruptcy on June 15, 2022. The Agreement was entered into on October 29, 2022, and was sealed by the United States Bankruptcy Court for the District of Delaware, pending the Government’s ongoing investigation. Under the terms of the Agreement, STIMWAVE has accepted responsibility for its conduct by, among other things: (i) making admissions and stipulating to the accuracy of an extensive Statement of Facts; (ii) paying a $10,000,000 monetary penalty; and (iii) maintaining an adequate compliance program, to include employing a Chief Compliance Officer and holding regular compliance committee meetings. STIMWAVE is also required to cooperate fully with the Government. STIMWAVE’s obligations under the Agreement will continue for a period of three years from the date of execution of the Agreement.
The U.S. Attorney’s Office also unsealed a civil fraud lawsuit filed against STIMWAVE under the False Claims Act (“FCA”), and the parties’ settlement of that suit (the “FCA Settlement”). The settlement has been submitted to United States District Judge George B. Daniels for approval. In connection with the FCA Settlement, STIMWAVE admitted and accepted responsibility for conduct alleged in the Government’s civil complaint and agreed to pay $8,600,000 to the United States. This payment will be credited towards the $10,000,000 monetary penalty discussed above. The civil complaint also brings claims against PERRYMAN under the FCA, which are pending.
U.S. Attorney Damian Williams said: “As alleged, at the direction of its founder and CEO Laura Perryman, Stimwave created a dummy medical device component — made entirely of plastic — designed to be implanted in patients for the sole purpose of causing doctors to unwittingly bill Medicare and private insurance companies more than $16,000 for each implantation of the piece of plastic. The defendant and Stimwave did this so that they could charge medical providers many thousands of dollars for purchasing their medical device. Our Office will continue to do everything in its power to bring to justice anyone responsible for perpetuating health care fraud, which in this case led to patients being used as nothing more than tools for financial enrichment.”
FBI Assistant Director Michael J. Driscoll said: “Ms. Perryman, as the Chief Executive Officer of Stimwave, allegedly led a scheme to sell medical devices that contained a non-functioning component that doctors unwittingly implanted into patients suffering from chronic pain. As a result of her illegal actions, not only did patients undergo unnecessary implanting procedures, but Medicare was defrauded of millions of dollars. Today’s action demonstrates the FBI’s continuing commitment to protect Medicare and other government programs from financial fraud and abuse.”
FDA-OIC Special Agent in Charge Fernando P. McMillan said: “Individuals and companies that manufacture and distribute medical devices with non-functional components put the health of patients at significant risk. We will continue to pursue and bring to justice those who jeopardize the health of their patients and of the public.”
According to the documents unsealed today in Manhattan federal court and the United States Bankruptcy Court for the District of Delaware:[1]
STIMWAVE was a medical device company that manufactured and distributed implantable neurostimulation devices designed to treat intractable, chronic pain. Founded in 2010 by PERRYMAN and others, STIMWAVE was headquartered in Pompano Beach, Florida.
STIMWAVE was founded on the premise that its products would provide non-opioid alternatives to chronic pain management. As the founder and CEO of STIMWAVE, PERRYMAN oversaw the design of the StimQ PNS System (the “Device”), a neurostimulator medical device that treated chronic pain by producing electrical currents to target peripheral nerves outside the spinal cord. From at least in or about 2017 up to and including her termination in or about 2019, PERRYMAN, as STIMWAVE’s CEO, engaged in a multi-year scheme (the “Scheme”) to design, create, manufacture, and market an inert, non-functioning component of the Device — called the “White Stylet” — that served no medical purpose but was included with the Device through in or about 2020 in order to make the product financially viable for doctors to purchase.
When STIMWAVE originally brought the Device to market in or about 2017, it contained three primary components: (i) an implantable electrode array (the “Lead”) that stimulated the nerve; (ii) an externally worn battery that sat outside the body and wirelessly provided power to the Lead through the patient’s skin (the “Battery”); and (iii) a separate implantable receiver measuring approximately 23 centimeters in length with a distinctive pink handle — called the “Pink Stylet.” The Pink Stylet contained copper and, unlike the White Stylet, functioned as a receiver to transmit energy from the Battery to the Lead.
STIMWAVE sold the Device to doctors and medical providers for over approximately $16,000. Medical insurance providers, including Medicare, would reimburse medical practitioners for implanting the Device into patients through two separate reimbursement codes, one for implantation of the Lead and a second for implantation of the Pink Stylet. The billing code for implanting the Lead provided for reimbursement at a rate of between approximately $4,000 and $6,000, while the billing code for implanting a receiver, like the Pink Stylet, provided for reimbursement at a rate of between approximately $16,000 and $18,000.
Soon after the Device was released, physicians informed STIMWAVE that they were having trouble implanting the Pink Stylet in certain patients because the Pink Stylet was too long. STIMWAVE and PERRYMAN knew that the Pink Stylet could not be cut or trimmed to shorten it without interfering with the functionality of the Pink Stylet as a receiver, and without a receiver component for doctors to implant and seek reimbursement for, doctors would incur a substantial financial loss with every purchase of the Device, thereby making it more difficult for STIMWAVE to sell the Device to doctors and medical providers at the approximately $16,000 price.
However, STIMWAVE — at the direction of PERRYMAN — did not lower the price of the Device so that its cost to doctors and medical providers could be covered by reimbursement for the implantation of only the Lead, nor did PERRYMAN recommend that doctors not implant the Device or its receiver component in cases where the Pink Stylet could not fit comfortably. Instead, PERRYMAN directed that STIMWAVE create the White Stylet — a dummy component made entirely of plastic that served no medical purpose but which STIMWAVE misrepresented to doctors as a customizable receiver alternative to the Pink Stylet. The White Stylet could be cut to size by the doctor for use in smaller anatomical spaces and was created solely so that doctors and medical providers would continue to purchase the Device for use in those scenarios and continue to bill for the implantation of a receiver component. To perpetuate the lie that the White Stylet was functional, PERRYMAN oversaw training that suggested to doctors that the White Stylet was a “receiver,” when, in fact, it was made entirely of plastic, contained no copper, and therefore had no conductivity. In addition, PERRYMAN directed other STIMWAVE employees to vouch for the efficacy of the White Stylet, when she knew that the White Stylet was actually non-functional.
As a result of these misrepresentations regarding the functionality of the White Stylet, PERRYMAN caused doctors and medical providers to unwittingly implant the non-functional White Stylet into patients and submit fraudulent reimbursement claims for implantation of the White Stylet to Medicare, resulting in millions of dollars in losses to the federal government.
On June 15, 2022, STIMWAVE filed for bankruptcy in Delaware under Chapter 11 of the Bankruptcy Code, through which it sold substantially all of its assets to a third-party through an auction.
* * *
PERRYMAN, 54, of Delray Beach, Florida, has been charged with one count of conspiracy to commit wire fraud and health care fraud, which carries a maximum potential sentence of 20 years in prison, and one count of health care fraud, which carries a maximum potential sentence of 10 years in prison.
The maximum potential sentences are prescribed by Congress and are provided here for informational purposes only, as any sentencing of the defendant will be determined by the judge.
Mr. Williams praised the investigative work of the FBI and thanked the FDA for its assistance.
The criminal case is being handled by the Complex Frauds and Cybercrime Unit of the Office’s Criminal Division. Assistant U.S. Attorneys Louis A. Pellegrino, Jacob M. Bergman, and Mónica P. Folch are in charge of the prosecution. The civil case against STIMWAVE and PERRYMAN is being handled by the Civil Frauds Unit of the Office’s Civil Division. Assistant U.S. Attorneys Jacob M. Bergman and Mónica P. Folch are in charge of the civil case.
The charges contained in the Indictment are merely accusations, and the defendant is presumed innocent unless and until proven guilty.
[1] As the introductory phrase signifies, the entirety of the text of the Indictment constitutes only allegations, and every fact described herein should be treated as an allegation.
The idea was simple. Recruit hundreds of people in their 80s and 90s, equip them with fitness trackers, and monitor their physical activity. Then, when the participants died, collect their brains and examine the tissue. Is there evidence, lurking in the tissue, that exercise benefits the brain?
The results, from a 2022 collaboration between the University of California in San Francisco and the University of British Columbia, were striking. Physical exercise, late in life, seemed to protect the ageing connections between brain cells – the synapses where memories are made. The work, if backed up by further studies, could see exercise, and potentially drugs that mimic biochemical aspects of activity – prescribed to help slow the onset of dementia.
“We know there is a 30{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}-80{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} reduced risk of dementia in people who exercise,” says Kaitlin Casaletto, the lead author on the study and an assistant professor in neurology at UCSF. “My question was, wouldn’t it be cool if we could figure out exactly how this is happening? If we could identify some of the mechanisms of exercise for brain health? These are potential therapeutic targets we can bottle.”
A small mountain of work has linked physical exercise to better brain health and lower risk of dementia in older age. One recent study of nearly 80,000 people in the UK found that the risk of dementia was halved in people who reached the goal of 10,000 steps a day. But much is still unclear. Part of the observed benefit could be down to people with healthier brains simply exercising more. While there are definite benefits to be had from exercise – greater blood flow to the brain, better cardiovascular health, lower blood pressure, less obesity and diabetes – there is still plenty to nail down.
Dementia is the number one killer in the UK, with the disorder affecting about 900,000 people. Most cases, about two-thirds, are driven by Alzheimer’s disease, but it is far from the only cause. Other forms, namely vascular dementia, dementia with Lewy bodies, and frontotemporal dementia, arise from other processes. Whatever the cause, the steady destruction of brain cells erodes memory, thinking, movement and personality. In old age, dementia can be several of these conditions at once.
Some of the highest rates of dementia are found in developed countries with older populations. In Germany, Italy and Japan, more than 20 in every 1,000 people have dementia compared with fewer than nine per 1,000 in proportionally younger countries including Mexico, Turkey and South Africa. The UK sits in the middle. Indigenous groups in the Amazon have some of the lowest rates. In one recent study, researchers confirmed only six cases among 604 Bolivian Tsimane and Moseten people aged 60 and over, suggesting that lifelong physical activity and healthier preindustrial diets substantially reduce the risk. Over the next three decades, global dementia is due to rise substantially, particularly in north Africa, the Middle East and eastern sub-Saharan Africa, where population growth and ageing will be among the driving forces.
But dementia is not inevitable, nor is it the reward for dodging other fatal conditions. Take all of the risk factors that we as individuals, or nations through their policies, might improve, and potentially 40{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of cases could be prevented or delayed. We would not eradicate dementia, and many people who did everything to keep their brains healthy would still succumb to the disease. We could, however, dramatically reduce the risk, meaning more years of sound thinking, intact memories and independent living. “That figure, 40{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}, is an enormous percentage,” says James Rowe, professor of cognitive neurology at the University of Cambridge. “If we had a drug that could cut dementia by 40{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}, it would be a phenomenal success.”
Our brains change even with healthy ageing. People vary tremendously, but vocabulary often improves past retirement age, while processing speed, the ease of learning new information, cognitive flexibility, and working memory – for example, how many digits of a phone number you can remember – weaken. Learning more slowly in older age is often framed as a negative, but it has its advantages. Young people know so little that learning everything fast makes sense. But older people weigh new information against a lifetime’s learning. Does it fit with what I know to be true? Is it reliable? Does it deserve to be learned? “When you are born, you are fast but know little. When you are old, you are slower but knowledgeable. Which is better? It depends on the situation,” says Rowe.
Dementia is very different to healthy ageing. It is what happens when brain cells are destroyed by disease. A healthy older person can expect a gradual decline in memory and thinking skills, but people with dementia can develop profound problems with memory, judgment, language, concentration and personality. The sharp decline in performance is mirrored by a pronounced shrinkage of the brain.
Last year, researchers at the universities of Cambridge and Pennsylvania stitched together 125,000 brain scans to reveal how the human brain changes from a 15-week-old foetus to a 100-year-old adult. The work was a tour de force. Ultimately, it should allow doctors to assess how a person’s brain is ageing over their lifetime, much as paediatric growth charts allow them to check whether children are developing normally. For example, a person’s brain might be in the 50th centile at age 45, but if it falls significantly on subsequent scans there may be a problem. The researchers already see stark shifts in scans from people diagnosed with Alzheimer’s. “We see those individuals crashing through the centiles,” says Richard Bethlehem, an assistant professor in neuroinformatics at Cambridge.
Because dementia is seen as a problem of old age, this might seem like the time to act. But ageing is a lifelong process: the better the brain ages, the better it can stave off or withstand dementia. “A lot of the seeds of poor brain health, including dementia, are sown well and truly in childhoodand then built on through early adult life and middle age,” says Rowe. “The state of our brain health in late life, when we are conventionally worried about dementia, depends on a whole lifespan of lifestyle and activities.”
In 2020, 28 world leading experts published a major report called the Lancet Commission on dementia. It identifies a dozen “potentially modifiable” factors that affect our risk of developing dementia. Which matters most depends on age. In youth, a good education makes an enormous difference, and benefits brain health for the rest of life. In midlife, not boozing too heavily and controlling blood pressure all come into play. In later life, not smoking, exercising regularly and keeping socially engaged stand out.
How these help to prevent dementia is not always straightforward. A good education doesn’t happen in a vacuum. It can reflect a child’s circumstances: their home environment, household income and expectations all play a part in sculpting the brain. Armed with a good education, people are better equipped to look after themselves. But education seems to act directly on the brain too, creating what researchers call cognitive reserve and resilience. Build up brain capacity early in life and that reserve becomes a shield against future damage. Likewise, education boosts resilience, the brain’s ability to compensate when diseases like Alzheimer’s arise. The impact can be striking. “For people with a very high education, when you look at the brain postmortem, they can have a lot of neuropathology without having had any symptoms,” says Gill Livingston, professor of psychiatry of older people at University College London and lead author of the Lancet report. In short, the disease is there, but the brain can withstand it, at least to the point that obvious symptoms never manifest.
According to the Lancet Commission, poor education accounts for 7{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of dementia worldwide. But the benefits of stretching one’s brain don’t end in youth. People who do cognitively challenging jobs have a lower risk of dementia, too, regardless of their education. As the Lancet report puts it: “The use it or lose it hypothesis suggests that mental activity, in general, might improve cognitive function.” The impact of other brain-stretching activities is far from clear, however. Despite a flurry of brain training programmes being developed to boost cognitive skills, there is no good evidence that people improve at anything apart from the particular task they practise.
One message that runs through all the research on dementia prevention is that a healthy lifestyle helps. Diet is important: you cannot grow a good brain without good nutrition, and a healthy diet helps to maintain it. A recent meta-analysis of studies, involving nearly 35,000 people, found that strict adherence to the Mediterranean diet was associated with a 21{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} lower risk of cognitive disorders and a 40{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} lower risk of Alzheimer’s. Whether specific nutrients and compounds are directly beneficial to the brain is the focus of intensive research, but healthy diets are encouraged regardless, because they reduce risks caused by other disorders, such as high blood pressure, poor vascular health, obesity and diabetes.
Which single intervention could reduce dementia risk the most? The answer is one that even some researchers find surprising: preventing hearing loss. Globally, hearing impairment is believed to account for about 8{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of dementia. Hearing loss means less stimulation for the brain, but also more social isolation for the individual. The brain appears to shrink more rapidly, or at least the temporal lobes, which focus on sound processing, emotions and memories. What’s striking is that the link between hearing loss and dementia is all but absent if people wear hearing aids. Livingston believes this is a huge opportunity. While people with poor eyesight tend to have it corrected, a large proportion of those who cannot hear well either think other people mumble, or are reluctant to wear a hearing aid. Correcting hearing loss as well as we correct poor sight could be a gamechanger, if enacted globally. “I think wearing a hearing aid is still stigmatised,” Livingston says, but she wonders, with more and more people now wearing earbuds, whether that barrier will soon fall too.
The picture emerging from decades of research is that the best protection against dementia comes from building a good brain, keeping it healthy and active, and avoiding too much damage. The latter can happen in seconds or years. Brain injuries, from traffic accidents, military service, falls, or impacts during sports such as boxing, rugby and horse riding, all increase the risk of dementia. So does the sustained damage that comes with smoking, air pollution and excessive alcohol intake – over 21 units a week. Brain injuries are thought to account for about 3{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of dementia, with heavy drinking and smoking making up 1{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} and 5{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} respectively. Air pollution accounts for around 1{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of dementia.
As might be expected, some experts in the field already take steps to reduce their risk. Because it is unclear which exercises are most protective, Dr Casaletto does weekly yoga, but she also jogs and includes high-intensity sprints in her routine. She eats healthily, maximising the vegetables, whole grains, olive oil, fish and legumes of the Mediterranean diet. Then there is the cognitive component. She tries to stay socially and mentally curious – pushing herself at work, broadening her collaborations, and hanging out with people she wouldn’t normally socialise with. “I think novelty is really important,” she says. “If we are doing the same thing over and over, we are not going to be pushing our brains into forming new connections.”
As part of her own risk-reducing lifestyle, Prof Livingston lifts weights and tries to reach 10,000 steps a day, even though she acknowledges it is “not a magic number”. She reads and writes. And she is wary of the impact of giving up work. “I can see that not being retired keeps you so much more active in lots of ways,” she says. “It might make me less likely to retire. Though I do hope that if I get to the stage when I ought to because I can’t function, that my colleagues will tactfully let me know.”
Four changes to make now
Dementia research, like all research, comes with caveats. Most studies cannot prove that doing X instead of Y helps fend off dementia. More commonly, scientists find associations, such as older people who exercise develop less dementia. But there is always the risk of reverse causation. What if people prone to dementia simply exercise less? Whether, and to what extent, exercise protects people’s brains can take some unpicking. The bottom line on whether this or that action keeps dementia at bay is rarely clear cut. Often the picture emerges with time, as evidence builds from different directions. But these are some things that you can do to help reduce the risk.
Get sweaty
Illustration: Fran Pulido/The Guardian
Keeping physically active matters. By combining the results from multiple studies, scientists find have found time and again that dementia and Alzheimer’s are less common in people who exercise. Sustained exercise in midlife, and possibly later life, appears to protect against dementia. A mix of aerobic exercise and strength training seems most effective. For aerobic exercise, breaking into a sweat at least once a week or doing more than 150 minutes of moderate to vigorous exercise each week have both been shown to be protective. How exercise helps is a focus of ongoing research, but at the least, it can reduce the risk of obesity and diabetes while boosting cardiovascular fitness, all of which lower dementia risk. Other gains can be had from quitting smoking and not drinking too much alcohol.
Use a hearing aid (if you need one)
Illustration: Fran Pulido/The Guardian
Less intuitive than mental and physical fitness is the impact of hearing loss. Poor hearing in middle age is thought to be one of the most significant drivers of dementia that people can act on. The mechanisms are still being teased out, but brain scans have linked poor hearing to faster brain shrinkage, itself a driver of dementia. Hearing loss also drives up social isolation, which compounds the problem, as people withdraw from social gatherings and the conversations they entail. But there is good news emerging: the marked declines seen in people with hearing impairments are not as dramatic in people who wear hearing aids, suggesting that correcting the problem can help keep dementia at bay.
Keep on learning
Illustration: Fran Pulido/The Guardian
A good chunk of people’s resilience to dementia comes from early life education. But even after school or university, keeping the brain mentally engaged matters. It is important for the brain to be making new connections. This means challenging yourself mentally, setting your brain to work on varied, unfamiliar and cognitively complex issues. A mentally challenging job may help, but so should lifelong learning, engaging hobbies and keeping socially active, especially if you mixing with people you wouldn’t normally hang out with. Being more sociable in your 50s and 60s is linked to better cognitive performance and a lower risk of dementia later in life, perhaps because it gets people using their memory and language skills. Keeping the brain active builds “cognitive reserve”, researchers say, meaning the brain is better able to cope as the pathologies that drive dementia take hold.
Prioritise dental hygiene
Illustration: Fran Pulido/The Guardian
One of the more speculative ideas on how to reduce dementia risk comes from research into bugs in the mouth. A recent study in the US found that people with gum disease and mouth infections were more likely to develop Alzheimer’s, the most common cause of dementia. Work is now under way to check whether bacteria such as Porphyromonas gingivalis help drive the condition, or simply proliferate in people in the early stages of dementia. If bacteria raise the risk, there will be even more reason to properly brush and floss twice a day.